Approvals/TGA/TREMFYA guselkumab 200 mg / 20 mL concentrated solution for intravenous infusion, vial

Approved

STANDARD

TREMFYA guselkumab 200 mg / 20 mL concentrated solution for intravenous infusion, vial

Janssen-Cilag Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6b91e6d775708525
Product Name: TREMFYA guselkumab 200 mg / 20 mL concentrated solution for intravenous infusion, vial
Artg Id: 460503
Artg Name: TREMFYA guselkumab 200 mg / 20 mL concentrated solution for intravenous infusion, vial
Sponsor: Janssen-Cilag Pty Ltd
Company Detail Path: /organization/janssen-cilag-pty-ltd
Artg Date: 2025-07-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

6b91e6d775708525

Type

Standard